Skip navigation

Refine by Type

Results 1 - 10 of 12 for AZACITIDINE
  1. Azacitidine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces ... and does not produce enough healthy blood cells). Azacitidine is in a class of medications called demethylation ...
  2. ... lessen the need for red blood cell transfusions. Azacitidine and decitabine Azacitidine and decitabine are used to treat myelodysplastic syndromes ... to work the way they should. Treatment with azacitidine and decitabine may slow the progression of myelodysplastic ...
  3. ... approved 3 medicines to treat MDS. They are: ● Azacitidine (Vidaza®) ● Decitabine (Dacogen®) ● Lenalidomide (Revlimid®) Azacitidine (Vidaza®) Given Through an IV Azacitidine was the ...
  4. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Arzerra (Ofatumumab) Asparaginase Erwinia chrysanthemi Avastin (Bevacizumab) Axitinib Azacitidine Back to Top B BEACOPP Becenum (Carmustine) Beleodaq ( ... Mechlorethamine Hydrochloride) Mutamycin (Mitomycin C) Myleran (Busulfan) Mylosar (Azacitidine) Mylotarg (Gemtuzumab Ozogamicin) Back to Top N Nanoparticle ...
  5. ... Doxorubicin Hydrochloride) Adriamycin RDF (Doxorubicin Hydrochloride) Arsenic Trioxide Azacitidine Cerubidine (Daunorubicin Hydrochloride) Clafen (Cyclophosphamide) Cyclophosphamide Cytarabine Cytosar- ...
  6. Myelodysplastic Syndromes (MDS) -- Overview Interactive Tutorial (Patient Education Institute)  
    ... approved by the FDA to treat MDS include azacitidine (Vidaza ®), decitibine (Dacogen ®) and lenalidomide (Revlimid ®). 5. Intensive ... by the FDA to treat MDS such as azacitidine, decitibine and lenalidomide • Immunosuppressive therapy • Chemotherapy • Stem Cell ...
  7. Facts Spring 2014 (Leukemia & Lymphoma Society) - PDF  
    ... vorinostat (Zolinza®); hypomethylating or demethylating agents such as azacitidine (Vidaza®) and decitabine (Dacogen®); immunomodulators such as lenalidomide ( ...
  8. ... been useful for a small number of patients. Azacitidine (Vidaza®) and decitabine (Dacogen®), approved for treating MDS, ... for treating CMML patients. However, the effectiveness of azacitidine and decitabine for CMML treatment requires further study. ...
  9. List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012 (Centers for Disease Control and Prevention) - PDF  
    ... 2,3,4,5 10:00 Antineoplastic agents Azacitidine 3,5 Not in AHFS (antineoplastic agent) Azathioprine ...
  10. Aplastic Anemia and Myelodysplastic Syndromes From the National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)  
    ... normal blood cell production. Chemotherapy medications may include azacitidine (Vidaza), decitabine (Dacogen), or other anticancer medications. This ...
previous · 1 · 2 · next